Corvus Pharmaceuticals, Inc. — Director's Dealing 2017

Feb 10, 2017

SEC Form 5 — Annual Statement of Changes in Beneficial Ownership

Issuer: Corvus Pharmaceuticals, Inc. (CRVS)
CIK: 0001626971
Period of Report: 2016-12-31

Reporting Person: MILLER RICHARD A MD (Director, President and CEO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2016-10-28	Common Stock, $0.0001 par value	G	50000	$0.00	Disposed	1027293	Indirect
2016-10-28	Common Stock, $0.0001 par value	G	50000	$0.00	Disposed	977293	Indirect

Footnotes

F1: A portion of these shares is subject to a right of repurchase held by the Issuer.

F2: These shares are held by Richard A. Miller and Sandra J. Horning, Trustees of the Miller-Horning Family Trust u/a/d January 25, 1985 (the "Miller-Horning Trust"). Dr. Miller has shared voting, investment and dispositive power over the shares held by the Miller Horning Trust.